Precursor Condition
Cervical Intraepithelial Neoplasia Grade 2/3
CI-CAN-00004785Explore in graph →
Precursor9 active trials
- NCIt
- C94676
Loading cancer entity…
Loading cancer entity…
Precursor Condition
CI-CAN-00004785Explore in graph →
Clinical trials
29 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07545746 | Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya(ASCEND) | not yet recruiting | Phase 2 | 140 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT07606677 | Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women | not yet recruiting | — | 1,465 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER |
| 0 |
| May 26, 2026 |
| clinicaltrials |
| NCT07454915 | PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia | recruiting | Phase 2 | 138 | PapiVax Biotech, Inc.OTHER | 2 | May 6, 2026 | clinicaltrials |
| NCT04098744 | Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)(ART-CIN_IIB) | recruiting | Phase 2 | 78 | Frantz Viral Therapeutics, LLCINDUSTRY | 1 | Oct 2, 2025 | clinicaltrials |
| NCT07095478 | Safety and Efficacy of Oral Artesunate for Pre-cervical Cancer(NeoART-CIN) | not yet recruiting | Phase 2 | 28 | Metanoic Health Ltd.INDUSTRY | 1 | Jul 31, 2025 | clinicaltrials |
| NCT02149030 | Effectiveness of Cervical Screening in HPV Vaccinated Women(HPV-004) | active not recruiting | N/A | 6,958 | Tampere UniversityOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT04755517 | Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400)(HPV400) | enrolling by invitation | N/A | 14,000 | Tampere University HospitalOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT06326294 | Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique | recruiting | N/A | 4,844 | Instituto Nacional de Saúde, MozambiqueOTHER_GOV | 1 | May 22, 2024 | clinicaltrials |
| NCT06273553 | A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3 | not yet recruiting | Phase 1 / Phase 2 | 39 | RinuaGene Biotechnology Co., Ltd.INDUSTRY | 0 | Feb 22, 2024 | clinicaltrials |
| NCT05405270 | Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment(PRedICT-TOPIC) | recruiting | — | 410 | Catharina Ziekenhuis EindhovenOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT03064087 | Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples(VALHUDES) | active not recruiting | — | 500 | Marc ArbynOTHER_GOV | 1 | Mar 29, 2023 | clinicaltrials |
| NCT04910802 | Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden | recruiting | Phase 4 | 150,000 | Miriam ElfströmOTHER_GOV | 1 | Sep 16, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Aug 27, 2026source: clinicaltrials